Cost-effectiveness of topiramate in migraine prevention: results from a pharmacoeconomic model of topiramate treatment

Autor: Joseph Menzin, Jeffrey S. Brown, Jeffrey D. Miller, Mark N. Friedman, Peter J. Neumann, George Papadopoulos
Rok vydání: 2005
Předmět:
Zdroj: Headache. 45(8)
ISSN: 0017-8748
Popis: OBJECTIVE Patients whose migraines are frequent, cause disruptions of daily routines, or are unresponsive to acute treatment are primary candidates for preventive migraine therapy. This cost-effectiveness model assesses the clinical and economic impact of topiramate (TPM) therapy versus no preventive treatment for migraine headache in the United States. BACKGROUND Despite significant progress in treatment options, the economic burden of migraine to patients, employers, health systems, and society is substantial. Treatment strategies for migraine are directed toward managing acute episodes. However, preventive therapy should be used for patients with frequent migraine attacks (>2 per month) or those experiencing attacks that disrupt daily routines. METHODS Data for the model were obtained from the published literature and pooled results of two randomized, double-blinded, placebo-controlled trials of TPM in migraine prevention. Model inputs included baseline migraine frequency (the base case assumed 6 per month, consistent with the average rate in the TPM trials), treatment discontinuation (including discontinuation due to adverse events), treatment response (ie, > or = 75%, 50% to 75%, and
Databáze: OpenAIRE